Company Quick10K Filing
Vitality BioPharma
10-Q 2020-12-31 Filed 2021-01-29
10-Q 2020-09-30 Filed 2020-11-13
10-Q 2020-06-30 Filed 2020-08-14
10-K 2020-03-31 Filed 2020-06-29
10-Q 2019-12-31 Filed 2020-02-14
10-Q 2019-09-30 Filed 2019-11-14
10-Q 2019-06-30 Filed 2019-08-13
10-K 2019-03-31 Filed 2019-07-15
10-Q 2018-12-31 Filed 2019-02-14
10-Q 2018-09-30 Filed 2018-11-14
10-Q 2018-06-30 Filed 2018-08-14
10-K 2018-03-31 Filed 2018-06-28
S-1 2018-01-19 Public Filing
10-Q 2017-12-31 Filed 2018-02-14
10-Q 2017-09-30 Filed 2017-11-14
10-Q 2017-06-30 Filed 2017-08-10
10-K 2017-03-31 Filed 2017-06-28
10-Q 2016-12-31 Filed 2017-02-14
10-Q 2016-09-30 Filed 2016-11-17
10-Q 2016-06-30 Filed 2016-08-16
10-K 2016-03-31 Filed 2016-06-24
10-Q 2015-12-31 Filed 2016-02-16
10-Q 2015-09-30 Filed 2015-11-16
10-Q 2015-06-30 Filed 2015-08-14
10-K 2015-03-31 Filed 2015-06-25
10-Q 2014-12-31 Filed 2015-02-17
10-Q 2014-09-30 Filed 2014-11-14
10-Q 2014-06-30 Filed 2014-08-14
10-K 2014-03-31 Filed 2014-06-30
10-Q 2013-12-31 Filed 2014-02-14
10-Q 2013-09-30 Filed 2013-11-05
10-Q 2013-06-30 Filed 2013-08-13
10-K 2013-03-31 Filed 2013-05-20
10-Q 2012-12-31 Filed 2013-02-15
10-Q 2012-09-30 Filed 2012-11-13
10-Q 2012-06-30 Filed 2012-08-14
10-K 2012-03-31 Filed 2012-07-13
10-Q 2011-12-31 Filed 2012-02-14
10-Q 2011-09-30 Filed 2011-11-14
10-Q 2011-06-30 Filed 2011-08-15
10-K 2011-03-31 Filed 2011-07-14
10-Q 2010-12-31 Filed 2011-02-15
10-Q 2010-09-30 Filed 2010-11-01
10-Q 2010-06-30 Filed 2010-08-23
10-K 2010-03-31 Filed 2010-07-14
10-Q 2009-12-31 Filed 2010-02-16
8-K 2020-09-24
8-K 2020-05-12
8-K 2020-04-21
8-K 2019-06-27
8-K 2019-06-14
8-K 2019-05-08
8-K 2019-04-22
8-K 2019-01-24
8-K 2019-01-18
8-K 2018-11-21
8-K 2018-11-15
8-K 2018-10-22
8-K 2018-10-19
8-K 2018-08-29
8-K 2018-04-05
8-K 2018-03-15

Vitality BioPharma Financials

VBIO Metrics, Comps, Filings

Quarterly | Annual

Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Equity

Income Statement ($MM Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($MM Quarterly)

Ops, Inv, Fin

Comps ($'000 TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
024 Pharma (EEIG)
11 Good Energy (ELVN)
1347 Capital Corp (TFSC)
CNB Financial (CCNE) 450,404 5.1 1% 3,541,170 3,244,137 0 0 38,542 77,627 398,243
1PM Industries (OPMZ)
1st Century Bancshares (FCTY)
1st Financial Services Corp (FFIS)
Timberline Resources (TLR)
Almost Never Films (HLWD)
1st United Bancorp (FUBC)
Manchester United (MANU) 0% 1,496,525 0 0 0 0 -307,637
SQL Technologies (SQFL) 18% 1.5 0% 6,991 29,884 9,299 1,628 0 1,813 2,696
2-Track Global (TTG)
GB Sciences (GBLX) 22,981 -23% -1.8 -56% 29,840 15,525 3,909 -891 -16,597 -12,951 23,417
Nemaura Medical (NMRD) 158,102 -32.0 -182% 2,704 2,507 0 0 -4,919 -4,879 156,331
Monroe Bank and Trust (MBTF) 231,777 -6.6 1% 1,326,547 1,191,110 0 0 10,048 16,197 -106,841
Solis Tek (SLTK) 43,678 51% -25.8 -163% 1,378 6,785 1,895 973 -2,244 -1,693 43,612
Cumulus Media (CMLS) -94.7 -0% 0 0 0 -10,600 1,003,622
Cyclo Therapeutics, Inc. (CYTHW)
ALABAMA POWER CO (APRCP)

Balance Sheet ($'000)2011-09-302011-12-312012-03-312012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash55175325335963921,1665511,8311,4038301,7821,0513901,1952089520341541,1535318151,3636561733377,4625,9834,6743,958
Accounts Receivable283940624377303928321925201314720461900
Inventory16193588866660
PP&E12
Assets58205358307915391,2826371,8851,4248831,8621,1354621,25229513569711961,1755598391,38267618336516,6146,0754,9174,197
Accounts Payable10388
Long-Term Debt6256256257626250
Liabilities2372425847761,1711,1082,2322,0971,6301,5351,4751,5431,6271,5422,1473796535839928778017465823993545187887461,0541,2481,644
Stockholders' Equity-179-222-4954-380-568-950-1,460254-110-591319-491-1,079-896-84-518-513-920-681374-187257982322-336-42315,8685,0213,6702,553
Income Statement ($'000)2011-09-302011-12-312012-03-312012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Revenue00000004112860586281544646403127311925264495
Cost of Revenue1264206724315425212042201717232615
Gross Profit306539-938500212520-1171322122
R&D04212412310032229246234366312184161125110130255410407421563508587530112599328295
SG&A75351,0117985914717267017967465679336565937425353633287076709206746026195985236841,0271,415852727
Tax0000000000000000000000000
Net Income-84-44-1,184-866-587-970-899-782-1,045-1,427-656-1,019-1,142-843216-84-778-439-1,147-2,500-1,114-1,106-899-1,242-1,062-1,135-1,114-1,209-9,557-1,591-1,227
Cash Flow ($'000)2011-09-302011-12-312012-03-312012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash Operating-53-100-383-381-359-615-538-589-518-731-662-486-213-340-239-305-501-622-710-848-483-586-1,229-859-715
Cash Investing0000011000
Cash Financing156554451781,133011051,470001,2921002652524251,50009951,395-250